ORAMED PHARMACEUTICALS INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Feb 2017 | — | $21.3M | $1.5M |
| May 2017 | — | $19.8M | $1.7M |
| Aug 2017 | — | $19.2M | $4.0M |
| Nov 2017 | — | $22.7M | $1.3M |
| Feb 2018 | — | $20.5M | $3.3M |
| May 2018 | — | $16.7M | $3.7M |
| Aug 2018 | $11.4M | $31.1M | $5.0M |
| Nov 2018 | — | $28.9M | $3.9M |
| Feb 2019 | — | $25.3M | $3.4M |
| May 2019 | — | $21.6M | $3.9M |
| Aug 2019 | $9.7M | $19.4M | $3.3M |
| Nov 2019 | — | $17.2M | $3.2M |
| Feb 2020 | — | $16.1M | $5.9M |
| May 2020 | — | $34.1M | $9.3M |
| Aug 2020 | — | $32.9M | $19.3M |
| Nov 2020 | — | $28.2M | $14.9M |
| Dec 2020 | — | $39.0M | $21.6M |
| Feb 2021 | — | $49.4M | $33.8M |
| Mar 2021 | — | $65.1M | $57.7M |
| May 2021 | — | $68.1M | $57.4M |
| Jun 2021 | — | $90.7M | $79.6M |
| Aug 2021 | $12.5M | $115.8M | $77.2M |
| Sep 2021 | — | $123.1M | $84.4M |
| Nov 2021 | $11.7M | $170.2M | $31.9M |
| Dec 2021 | $11.6M | $166.5M | $27.5M |
| Mar 2022 | $9.2M | $162.3M | $28.0M |
| Jun 2022 | $7.3M | $153.7M | $29.9M |
| Sep 2022 | $5.2M | $153.8M | $33.2M |
| Dec 2022 | $25.0K | $151.8M | $40.5M |
| Mar 2023 | — | $151.0M | $24.1M |
| Jun 2023 | — | $151.5M | $6.8M |
| Sep 2023 | $74.6M | $149.1M | $5.5M |
| Dec 2023 | — | $163.8M | $9.1M |
| Mar 2024 | — | $166.6M | $18.6M |
| Jun 2024 | — | $177.1M | $84.8M |
| Sep 2024 | — | $156.4M | $42.1M |
| Dec 2024 | — | $146.3M | $54.4M |
| Mar 2025 | — | $140.8M | $74.5M |
| Jun 2025 | — | $154.5M | $15.8M |
| Sep 2025 | — | $203.3M | $52.2M |
| Dec 2025 | — | $199.7M | $45.9M |
| Mar 2026 | — | $238.3M | $13.2M |
| Jun 2026 | — | $317.5M | $15.2M |